微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.1% | -92.54% | -95.78% | 57/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 2.37% | 4.87% | 28.8% | 43/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 1.84% | 264.29% | 14.29% | 51/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 1.61% | 161.45% | 20.15% | 44/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 1.34% | 482.61% | -40.71% | 44/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 2.26% | 156.78% | 301.79% | 52/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | -1.12% | 67.16% | 57.25% | 63/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | -2.62% | -187.91% | -1239.13% | 63/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 0.23% | 64.29% | 105.78% | 61/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -3.98% | -276.11% | -16.72% | 60/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | -3.41% | -293.75% | -274.73% | 65/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | -0.91% | -153.53% | -750% | 63/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.14% | -92.27% | -93.81% | 61/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 2.26% | 101.79% | 28.41% | 54/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 1.76% | -2.76% | 3.53% | 59/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 1.7% | -10.53% | -6.08% | 58/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.81% | -35.82% | 61.61% | 43/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 1.12% | -54.47% | -38.12% | 58/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 1.81% | -26.72% | -4.74% | 60/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 1.9% | 86.27% | -32.62% | 49/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.82% | 203.23% | 14.63% | 17/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 2.46% | 127.42% | -0.4% | 52/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 2.47% | 550% | 142.16% | 55/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 1.02% | 5200% | 9.68% | 60/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 0.93% | 564.29% | 110.37% | 54/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | -8.97% | -44950% | -2460.53% | 65/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 0.38% | 100% | 2000% | 62/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | -0.02% | 0% | -114.29% | 63/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 0.14% | 27.27% | 600% | 63/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 0.02% | 133.33% | -89.47% | 64/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 0.19% | 26.67% | 1050% | 62/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | -0.02% | 71.43% | -118.18% | 63/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 0.11% | 22.22% | 283.33% | 60/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | -0.06% | -120.69% | -140% | 61/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 0.15% | -6.25% | 314.29% | 57/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | -0.07% | -170% | -177.78% | 60/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 0.09% | 119.57% | -68.97% | 56/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 0.29% | -90% | 81.25% | 59/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 0.16% | -85.05% | 60% | 52/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 0.1% | -91.94% | 121.74% | 54/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | -0.46% | -209.52% | -115.86% | 53/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |